Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 166

1.

The brain, self and society: a social-neuroscience model of predictive processing.

Kelly MP, Kriznik NM, Kinmonth AL, Fletcher PC.

Soc Neurosci. 2018 May 10:1-11. doi: 10.1080/17470919.2018.1471003. [Epub ahead of print]

PMID:
29718764
2.

Perceptions of self-rated health among stroke survivors: a qualitative study in the United Kingdom.

Mavaddat N, Sadler E, Lim L, Williams K, Warburton E, Kinmonth AL, Mant J, Burt J, McKevitt C.

BMC Geriatr. 2018 Apr 2;18(1):81. doi: 10.1186/s12877-018-0765-8.

3.

Moving beyond individual choice in policies to reduce health inequalities: the integration of dynamic with individual explanations.

Kriznik NM, Kinmonth AL, Ling T, Kelly MP.

J Public Health (Oxf). 2018 Mar 13. doi: 10.1093/pubmed/fdy045. [Epub ahead of print]

PMID:
29546404
4.

Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.

Wright AJ, Sutton S, Armstrong D, Aveyard P, Kinmonth AL, Marteau TM.

Transl Behav Med. 2018 Jan 29;8(1):18-28. doi: 10.1093/tbm/ibx008.

PMID:
29385578
5.

Patients' views on interactions with practitioners for type 2 diabetes: a longitudinal qualitative study in primary care over 10 years.

Dambha-Miller H, Silarova B, Irving G, Kinmonth AL, Griffin SJ.

Br J Gen Pract. 2018 Jan;68(666):e36-e43. doi: 10.3399/bjgp17X693917. Epub 2017 Dec 4.

6.
7.

A randomised controlled trial of three very brief interventions for physical activity in primary care.

Pears S, Bijker M, Morton K, Vasconcelos J, Parker RA, Westgate K, Brage S, Wilson E, Prevost AT, Kinmonth AL, Griffin S, Sutton S, Hardeman W; VBI Programme Team.

BMC Public Health. 2016 Sep 30;16(1):1033.

8.

The effect of a brief action planning intervention on adherence to double-blind study medication, compared to a standard trial protocol, in the Atorvastatin in Factorial with Omega EE90 Risk Reduction in Diabetes (AFORRD) clinical trial: A cluster randomised sub-study.

Farmer AJ, Oke J, Hardeman W, Tucker L, Sutton S, Kinmonth AL, Griffin S, Holman RR.

Diabetes Res Clin Pract. 2016 Oct;120:56-64. doi: 10.1016/j.diabres.2016.07.004. Epub 2016 Jul 30.

PMID:
27522034
9.

Relationship of Self-Rated Health to Stroke Incidence and Mortality in Older Individuals with and without a History of Stroke: A Longitudinal Study of the MRC Cognitive Function and Ageing (CFAS) Population.

Mavaddat N, van der Linde R, Parker R, Savva G, Kinmonth AL, Brayne C, Mant J.

PLoS One. 2016 Feb 29;11(2):e0150178. doi: 10.1371/journal.pone.0150178. eCollection 2016.

10.

Patient-centred care, health behaviours and cardiovascular risk factor levels in people with recently diagnosed type 2 diabetes: 5-year follow-up of the ADDITION-Plus trial cohort.

Dambha-Miller H, Cooper AJ, Simmons RK, Kinmonth AL, Griffin SJ.

BMJ Open. 2016 Jan 6;6(1):e008931. doi: 10.1136/bmjopen-2015-008931.

11.

Health, welfare, and the state-the dangers of forgetting history.

Szreter S, Kinmonth AL, Kriznik NM, Kelly MP.

Lancet. 2016 Dec 3;388(10061):2734-2735. doi: 10.1016/S0140-6736(16)32429-1. Epub 2016 Dec 2. No abstract available.

PMID:
28328477
12.

Public attitudes towards pricing policies to change health-related behaviours: a UK focus group study.

Somerville C, Marteau TM, Kinmonth AL, Cohn S.

Eur J Public Health. 2015 Dec;25(6):1058-64. doi: 10.1093/eurpub/ckv077. Epub 2015 May 16.

13.

Long-term effect of population screening for diabetes on cardiovascular morbidity, self-rated health, and health behavior.

Echouffo-Tcheugui JB, Simmons RK, Prevost AT, Williams KM, Kinmonth AL, Wareham NJ, Griffin SJ.

Ann Fam Med. 2015 Mar;13(2):149-57. doi: 10.1370/afm.1737.

14.

Association of self-rated health with multimorbidity, chronic disease and psychosocial factors in a large middle-aged and older cohort from general practice: a cross-sectional study.

Mavaddat N, Valderas JM, van der Linde R, Khaw KT, Kinmonth AL.

BMC Fam Pract. 2014 Nov 25;15:185. doi: 10.1186/s12875-014-0185-6.

15.
16.

Relationship of self-rated health with fatal and non-fatal outcomes in cardiovascular disease: a systematic review and meta-analysis.

Mavaddat N, Parker RA, Sanderson S, Mant J, Kinmonth AL.

PLoS One. 2014 Jul 30;9(7):e103509. doi: 10.1371/journal.pone.0103509. eCollection 2014. Review.

17.

Implementation of a nurse-led behaviour change intervention to support medication taking in type 2 diabetes: beyond hypothesised active ingredients (SAMS Consultation Study).

Hardeman W, Lamming L, Kellar I, De Simoni A, Graffy J, Boase S, Sutton S, Farmer A, Kinmonth AL.

Implement Sci. 2014 Jun 5;9:70. doi: 10.1186/1748-5908-9-70.

18.

Which behavior change techniques are associated with changes in physical activity, diet and body mass index in people with recently diagnosed diabetes?

Hankonen N, Sutton S, Prevost AT, Simmons RK, Griffin SJ, Kinmonth AL, Hardeman W.

Ann Behav Med. 2015 Feb;49(1):7-17. doi: 10.1007/s12160-014-9624-9.

19.

Multiple behaviour change intervention and outcomes in recently diagnosed type 2 diabetes: the ADDITION-Plus randomised controlled trial.

Griffin SJ, Simmons RK, Prevost AT, Williams KM, Hardeman W, Sutton S, Brage S, Ekelund U, Parker RA, Wareham NJ, Kinmonth AL; ADDITION-Plus study team.

Diabetologia. 2014 Jul;57(7):1308-19. doi: 10.1007/s00125-014-3236-6. Epub 2014 Apr 24.

20.

Does electronic monitoring influence adherence to medication? Randomized controlled trial of measurement reactivity.

Sutton S, Kinmonth AL, Hardeman W, Hughes D, Boase S, Prevost AT, Kellar I, Graffy J, Griffin S, Farmer A.

Ann Behav Med. 2014 Dec;48(3):293-9. doi: 10.1007/s12160-014-9595-x.

21.

Predictors of change in objectively measured and self-reported health behaviours among individuals with recently diagnosed type 2 diabetes: longitudinal results from the ADDITION-Plus trial cohort.

Kuznetsov L, Simmons RK, Sutton S, Kinmonth AL, Griffin SJ, Hardeman W; ADDITION-Plus study team.

Int J Behav Nutr Phys Act. 2013 Oct 23;10:118. doi: 10.1186/1479-5868-10-118.

22.

Changes in diet, cardiovascular risk factors and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort.

Savory LA, Griffin SJ, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Simmons RK.

Diabet Med. 2014 Feb;31(2):148-55. doi: 10.1111/dme.12316. Epub 2013 Oct 21.

23.

Trials to improve blood pressure through adherence to antihypertensives in stroke/TIA: systematic review and meta-analysis.

De Simoni A, Hardeman W, Mant J, Farmer AJ, Kinmonth AL.

J Am Heart Assoc. 2013 Aug 20;2(4):e000251. doi: 10.1161/JAHA.113.000251. Review.

24.

Self-rated health and cardiovascular disease incidence: results from a longitudinal population-based cohort in Norfolk, UK.

van der Linde RM, Mavaddat N, Luben R, Brayne C, Simmons RK, Khaw KT, Kinmonth AL.

PLoS One. 2013 Jun 3;8(6):e65290. doi: 10.1371/journal.pone.0065290. Print 2013.

25.

Using the 7-point checklist as a diagnostic aid for pigmented skin lesions in general practice: a diagnostic validation study.

Walter FM, Prevost AT, Vasconcelos J, Hall PN, Burrows NP, Morris HC, Kinmonth AL, Emery JD.

Br J Gen Pract. 2013 May;63(610):e345-53. doi: 10.3399/bjgp13X667213.

26.

The cost-effectiveness of a novel SIAscopic diagnostic aid for the management of pigmented skin lesions in primary care: a decision-analytic model.

Wilson EC, Emery JD, Kinmonth AL, Prevost AT, Morris HC, Humphrys E, Hall PN, Burrows N, Bradshaw L, Walls J, Norris P, Johnson M, Walter FM.

Value Health. 2013 Mar-Apr;16(2):356-66. doi: 10.1016/j.jval.2012.12.008.

27.

Act now against new NHS competition regulations: an open letter to the BMA and the Academy of Medical Royal Colleges calls on them to make a joint public statement of opposition to the amended section 75 regulations.

Davis J, Banks I, Wrigley D, Peedell C, Pollock A, McPherson K, McKee M, Irving WL, Crome P, Greenhalgh T, Holland W, Evans D, Maryon-Davis A, Smyth A, Fleming P, Coleman M, Sharp DJ, Whincup P, Logan S, Cook D, Moore R, Rawaf S, McEewen J, West R, Yudkin JS, Clarke A, Finer N, Domizio P, Bambra C, Jones A, Feder G, Scott-Samuel A, Irvine L, Sharma A, Fitchett M, Boomla K, Folb J, Paul A, McCoy D, Tallis R, Burgess-Allen J, Edwards M, Tomlinson J, Colvin D, Gore J, Brown K, Mitchel S, Lau A, Sayer M, Clark L, Silverman R, Marmot S, Rainbow D, Carter L, Mann N, Fielding R, Logan J, Tebboth L, Arnold N, Stobbart K, Cabot K, Finer S, Edwards M, Davies D, Buttivant H, Kraemer S, Newell J, Griffiths A, Fitzgerald R, Macgibbon R, Lee A, Macklon AF, Hobson E, Jenner D, Jacobson B, Timmis A, Salim A, Evans-Jones J, Caan W, Awsare N, Pride N, Suckling R, Bratty C, Rossiter B, Hawkins D, Currie J, Camilleri-Ferrante C, Fluxman J, Bhatti O, Anson J, Etherington R, Lawrence D, Fell H, Clarke E, Ormerod J, Ormerod O, Ireland M, Duncan JA, Chandy R, Mindell J, Mullen P, Bennett-Richards P, Hirst J, Murphy E, Martin P, Lowes S, Fleming P, Grunewald R, Reeve J, Schweiger M, Coates J, Farrelly G, Chamberlain MA, Lewis G, Young J, Scott B, Gibbs J, Landers A, Deveson P, Ingrams G, Leigh M, Gawler J, Ford A, Nixon J, McCartney M, Bareford D, Singh S, Lockwood K, Cripwell M, Ehrhardt P, Bell D, Wortley P, Tomlinson L, Hotchkiss J, Ford S, Turner G, Reissman G, Lewis D, Johnstone C, Tomson M, Torabi P, Bell D, Tomson D, Tulloch A, Johnston S, Dickinson J, McElderry E, Ross W, Holt K, Logan M, Klonin H, Jenner D, Danby J, Goodger V, Puntis J, Dickson H, Gould DA, Livingstone A, Lefevre D, Kendall B, Singh G, Hall P, Darling J, Hamlyn AN, Patel A, Erskine J, Fisher B, Hughes R, Highton C, Venning H, Singer R, Brearey S, Sikorski J, Paintin D, Feehally J, Savage W, Freud KM, Holt VJ, Gill A, Waterston T, Souza Rd, Hopkinson N, Beadsworth M, Franks A, Daley H, Cullinan P, Basarab A, Folb J, Gurling H, Zinkin P, Kirwin S, Buhrs E, Brown R, West A, Marlowe G, Fellows G, Main J, Applebee J, Koperski M, Jones P, Macfarlane A, Beer N, Mason R, West R, Eisner M, Smailes A, Timms P, Knight D, Jones C, Wesby B, Lyttelton L, Morrison R, Bossano D, Walker J, Davies G, Godfrey P, Wolfe I, Nsutebu E, Stevenson N, Cheeroth S, Miller J, Johnson G, Noor R, Hall A, Bostock D, Michael B, Sharvill J, Macpherson J, Lewis D, Ma R, Middleton J, Jeffreys A, Cole J, Boswell JP, Bury B, Mitchison S, Kinmonth AL, Young G, Maclennan I, Munday P.

BMJ. 2013 Mar 20;346:f1819. doi: 10.1136/bmj.f1819. No abstract available.

PMID:
23516260
28.

Republished research: effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials.

Orrow G, Kinmonth AL, Sanderson S, Sutton S.

Br J Sports Med. 2013 Jan;47(1):27. doi: 10.1136/bjsports-2012-e1389rep.

PMID:
23243114
29.

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial.

Simmons RK, Echouffo-Tcheugui JB, Sharp SJ, Sargeant LA, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ.

Lancet. 2012 Nov 17;380(9855):1741-8. doi: 10.1016/S0140-6736(12)61422-6. Epub 2012 Oct 4.

30.

Changes in physical activity and modelled cardiovascular risk following diagnosis of diabetes: 1-year results from the ADDITION-Cambridge trial cohort.

Barakat A, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ, Simmons RK.

Diabet Med. 2013 Feb;30(2):233-8. doi: 10.1111/j.1464-5491.2012.03765.x.

31.

Effect of communicating DNA based risk assessments for Crohn's disease on smoking cessation: randomised controlled trial.

Hollands GJ, Whitwell SC, Parker RA, Prescott NJ, Forbes A, Sanderson J, Mathew CG, Lewis CM, Watts S, Sutton S, Armstrong D, Kinmonth AL, Prevost AT, Marteau TM.

BMJ. 2012 Jul 20;345:e4708. doi: 10.1136/bmj.e4708.

32.

Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial.

Walter FM, Morris HC, Humphrys E, Hall PN, Prevost AT, Burrows N, Bradshaw L, Wilson EC, Norris P, Walls J, Johnson M, Kinmonth AL, Emery JD.

BMJ. 2012 Jul 4;345:e4110. doi: 10.1136/bmj.e4110.

33.

Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort.

Charles M, Simmons RK, Williams KM, Roglic G, Sharp SJ, Kinmonth AL, Wareham NJ, Griffin SJ.

Br J Gen Pract. 2012 Jun;62(599):e396-402. doi: 10.3399/bjgp12X649070.

34.

Effect on adherence to nicotine replacement therapy of informing smokers their dose is determined by their genotype: a randomised controlled trial.

Marteau TM, Aveyard P, Munafò MR, Prevost AT, Hollands GJ, Armstrong D, Sutton S, Hill C, Johnstone E, Kinmonth AL.

PLoS One. 2012;7(4):e35249. doi: 10.1371/journal.pone.0035249. Epub 2012 Apr 11.

35.

An explanatory randomised controlled trial of a nurse-led, consultation-based intervention to support patients with adherence to taking glucose lowering medication for type 2 diabetes.

Farmer A, Hardeman W, Hughes D, Prevost AT, Kim Y, Craven A, Oke J, Boase S, Selwood M, Kellar I, Graffy J, Griffin S, Sutton S, Kinmonth AL.

BMC Fam Pract. 2012 Apr 5;13:30. doi: 10.1186/1471-2296-13-30.

36.

Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials.

Orrow G, Kinmonth AL, Sanderson S, Sutton S.

BMJ. 2012 Mar 26;344:e1389. doi: 10.1136/bmj.e1389. Review.

37.

Predictors of suboptimal glycaemic control in type 2 diabetes patients: the role of medication adherence and body mass index in the relationship between glycaemia and age.

Nagrebetsky A, Griffin S, Kinmonth AL, Sutton S, Craven A, Farmer A.

Diabetes Res Clin Pract. 2012 May;96(2):119-28. doi: 10.1016/j.diabres.2011.12.003. Epub 2012 Jan 17.

PMID:
22261095
38.

Adherence to hypoglycaemic medication among people with type 2 diabetes in primary care.

White AJ, Kellar I, Prevost AT, Kinmonth AL, Sutton S, Canny M, Griffin SJ.

Prim Care Diabetes. 2012 Apr;6(1):27-33. doi: 10.1016/j.pcd.2011.07.004. Epub 2011 Aug 12.

PMID:
21840277
39.

Can informed choice invitations lead to inequities in intentions to make lifestyle changes among participants in a primary care diabetes screening programme? Evidence from a randomized trial.

Kellar I, Mann E, Kinmonth AL, Prevost AT, Sutton S, Marteau TM.

Public Health. 2011 Sep;125(9):645-52. doi: 10.1016/j.puhe.2011.05.010. Epub 2011 Jul 20.

PMID:
21764087
40.

Do increases in physical activity encourage positive beliefs about further change in the ProActive cohort?

Hardeman W, Michie S, Kinmonth AL, Sutton S; ProActive project team.

Psychol Health. 2011 Jul;26(7):899-914. doi: 10.1080/08870446.2010.512662. Epub 2011 May 24.

PMID:
21500102
41.

Protocol for the ADDITION-Plus study: a randomised controlled trial of an individually-tailored behaviour change intervention among people with recently diagnosed type 2 diabetes under intensive UK general practice care.

Griffin SJ, Simmons RK, Williams KM, Prevost AT, Hardeman W, Grant J, Whittle F, Boase S, Hobbis I, Brage S, Westgate K, Fanshawe T, Sutton S, Wareham NJ, Kinmonth AL; ADDITION-Plus study team.

BMC Public Health. 2011 Apr 4;11:211. doi: 10.1186/1471-2458-11-211.

42.

Trial Protocol: Communicating DNA-based risk assessments for Crohn's disease: a randomised controlled trial assessing impact upon stopping smoking.

Whitwell SC, Mathew CG, Lewis CM, Forbes A, Watts S, Sanderson J, Hollands GJ, Prevost AT, Armstrong D, Kinmonth AL, Sutton S, Marteau TM.

BMC Public Health. 2011 Jan 19;11:44. doi: 10.1186/1471-2458-11-44.

43.

Predictors of anxiety and depression among people attending diabetes screening: a prospective cohort study embedded in the ADDITION (Cambridge) randomized control trial.

Paddison CA, Eborall HC, French DP, Kinmonth AL, Prevost AT, Griffin SJ, Sutton S.

Br J Health Psychol. 2011 Feb;16(Pt 1):213-26. doi: 10.1348/135910710X495366.

PMID:
21226792
44.

Theory of planned behaviour cognitions do not predict self-reported or objective physical activity levels or change in the ProActive trial.

Hardeman W, Kinmonth AL, Michie S, Sutton S.

Br J Health Psychol. 2011 Feb;16(Pt 1):135-50. doi: 10.1348/135910710X523481.

PMID:
21226788
45.

Impact of informed-choice invitations on diabetes screening knowledge, attitude and intentions: an analogue study.

Mann E, Kellar I, Sutton S, Kinmonth AL, Hankins M, Griffin S, Marteau TM.

BMC Public Health. 2010 Dec 17;10:768. doi: 10.1186/1471-2458-10-768.

46.

Trial Protocol: Using genotype to tailor prescribing of nicotine replacement therapy: a randomised controlled trial assessing impact of communication upon adherence.

Marteau TM, Munafò MR, Aveyard P, Hill C, Whitwell S, Willis TA, Crockett RA, Hollands GJ, Johnstone EC, Wright AJ, Prevost AT, Armstrong D, Sutton S, Kinmonth AL.

BMC Public Health. 2010 Nov 9;10:680. doi: 10.1186/1471-2458-10-680.

47.

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study.

Sargeant LA, Simmons RK, Barling RS, Butler R, Williams KM, Prevost AT, Kinmonth AL, Wareham NJ, Griffin SJ.

Diabet Med. 2010 Sep;27(9):995-1003. doi: 10.1111/j.1464-5491.2010.03056.x.

48.

What determines Self-Rated Health (SRH)? A cross-sectional study of SF-36 health domains in the EPIC-Norfolk cohort.

Mavaddat N, Kinmonth AL, Sanderson S, Surtees P, Bingham S, Khaw KT.

J Epidemiol Community Health. 2011 Sep;65(9):800-6. doi: 10.1136/jech.2009.090845. Epub 2010 Jun 15.

PMID:
20551149
49.

Impact of an informed choice invitation on uptake of screening for diabetes in primary care (DICISION): randomised trial.

Marteau TM, Mann E, Prevost AT, Vasconcelos JC, Kellar I, Sanderson S, Parker M, Griffin S, Sutton S, Kinmonth AL.

BMJ. 2010 May 13;340:c2138. doi: 10.1136/bmj.c2138.

50.

Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379].

Walter FM, Morris HC, Humphrys E, Hall PN, Kinmonth AL, Prevost AT, Wilson EC, Burrows N, Norris P, Johnson M, Emery J.

BMC Fam Pract. 2010 May 11;11:36. doi: 10.1186/1471-2296-11-36.

Supplemental Content

Loading ...
Support Center